Roser Torrá

11.8k total citations · 1 hit paper
160 papers, 5.2k citations indexed

About

Roser Torrá is a scholar working on Genetics, Molecular Biology and Nephrology. According to data from OpenAlex, Roser Torrá has authored 160 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Genetics, 72 papers in Molecular Biology and 55 papers in Nephrology. Recurrent topics in Roser Torrá's work include Genetic and Kidney Cyst Diseases (66 papers), Renal and related cancers (57 papers) and Renal Diseases and Glomerulopathies (45 papers). Roser Torrá is often cited by papers focused on Genetic and Kidney Cyst Diseases (66 papers), Renal and related cancers (57 papers) and Renal Diseases and Glomerulopathies (45 papers). Roser Torrá collaborates with scholars based in Spain, United Kingdom and United States. Roser Torrá's co-authors include Elisabet Ars, Célia Bádenas, José Ballarín, Eliécer Coto, David Ravine, Xavier Estivill, Martijn H. Breuning, Alejandro Darnell, York Pei and Nadja Bogdanova and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Roser Torrá

154 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

2015 384 citations Olivier Devuyst, Kai‐Uwe Eckardt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roser Torrá Spain	39	3.0k	2.6k	1.5k	728	725	160	5.2k
Bertrand Knebelmann France	46	1.3k 0.4×	3.0k 1.2×	1.7k 1.1×	554 0.8×	1.0k 1.4×	123	6.2k
Karin Dahan Belgium	26	759 0.3×	1.6k 0.6×	1.6k 1.1×	433 0.6×	519 0.7×	71	3.2k
Dominique Chauveau France	39	1.9k 0.6×	2.3k 0.9×	1.1k 0.8×	566 0.8×	1.2k 1.6×	160	5.1k
B. Mougenot France	29	242 0.1×	1.0k 0.4×	1.2k 0.8×	400 0.5×	547 0.8×	67	3.0k
Tobias Carling United States	45	1.2k 0.4×	1.8k 0.7×	1.7k 1.2×	913 1.3×	578 0.8×	151	6.5k
Daniel P. Gale United Kingdom	27	323 0.1×	656 0.2×	1.4k 1.0×	221 0.3×	314 0.4×	95	3.1k
Takako Morita Japan	15	362 0.1×	920 0.3×	1.2k 0.8×	329 0.5×	179 0.2×	71	2.3k
Steven G. Waguespack United States	46	1.2k 0.4×	1.2k 0.5×	599 0.4×	466 0.6×	630 0.9×	173	8.4k
Janet van Adelsberg United States	26	585 0.2×	918 0.3×	79 0.1×	241 0.3×	382 0.5×	49	2.6k
Andreas Schwarting Germany	38	217 0.1×	766 0.3×	695 0.5×	510 0.7×	451 0.6×	187	5.9k

Countries citing papers authored by Roser Torrá

Since Specialization

Citations

This map shows the geographic impact of Roser Torrá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roser Torrá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roser Torrá more than expected).

Fields of papers citing papers by Roser Torrá

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roser Torrá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roser Torrá. The network helps show where Roser Torrá may publish in the future.

Co-authorship network of co-authors of Roser Torrá

This figure shows the co-authorship network connecting the top 25 collaborators of Roser Torrá. A scholar is included among the top collaborators of Roser Torrá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roser Torrá. Roser Torrá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brand, Eva, Aleš Linhart, Patrick Deegan, et al.. (2025). Clinical management of female patients with Fabry disease based on expert consensus. Orphanet Journal of Rare Diseases. 20(1). 7–7. 5 indexed citations

Ortíz, Alberto, Motoko Yanagita, Hideki Yokoi, & Roser Torrá. (2025). Evolving strategies for early diagnosis, proactive prevention and treatment of CKD. Nephrology Dialysis Transplantation. 41(3). 418–427.

Furlano, Mónica, Marc Pybus, Víctor Martínez, et al.. (2024). Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants. Nephrology Dialysis Transplantation. 39(9). 1442–1448. 7 indexed citations

Hughes, Derralynn, Gere Sunder‐Plassmann, Ana Jovanović, et al.. (2024). Renal and multisystem effectiveness of 3.9 years of migalastat in a global real‐world cohort: Results from the followME Fabry Pathfinders registry. Journal of Inherited Metabolic Disease. 48(1). e12771–e12771. 7 indexed citations

Jankowska, Magdalena, María José Soler, Kate Stevens, & Roser Torrá. (2023). Why do we keep ignoring sex in kidney disease?. Clinical Kidney Journal. 16(12). 2327–2335. 10 indexed citations

Blasco, Miquel, Borja Quiroga, José Manuel García‐Aznar, et al.. (2023). Estudio genético en pacientes jóvenes con enfermedad renal crónica avanzada de etiología no filiada. Diseño del estudio GENSEN. SHILAP Revista de lepidopterología. 44(4). 568–575. 1 indexed citations

Bichet, Daniel G., Robert J. Hopkin, Sridhar R. Allam, et al.. (2023). Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat: a modified Delphi study. Frontiers in Medicine. 10. 1220637–1220637. 10 indexed citations

Pybus, Marc, Gemma Bullich, Mónica Furlano, et al.. (2021). Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players. Nephrology Dialysis Transplantation. 37(4). 687–696. 47 indexed citations

Furlano, Mónica, Ferràn Torres, Marc Pybus, et al.. (2021). Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease. Clinical Kidney Journal. 15(5). 912–921. 6 indexed citations

10.

Górriz, José Luis, David Arroyo, Luis D’Marco, et al.. (2021). Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease. BMC Nephrology. 22(1). 110–110. 6 indexed citations

11.

Torrá, Roser & Mónica Furlano. (2019). New therapeutic options for Alport syndrome. Nephrology Dialysis Transplantation. 34(8). 1272–1279. 33 indexed citations

12.

Petzold, Katja, Ron T. Gansevoort, Albert Ong, et al.. (2014). Building a network of ADPKD reference centres across Europe: the EuroCYST initiative. Nephrology Dialysis Transplantation. 29(suppl_4). iv26–iv32. 11 indexed citations

13.

Torrá, Roser, et al.. (2013). Hypertension in autosomal-dominant polycystic kidney disease (ADPKD). Clinical Kidney Journal. 6(5). 457–463. 16 indexed citations

14.

Torrá, Roser & Alberto Ortíz. (2012). Fabry disease: the many faces of a single disorder. Clinical Kidney Journal. 5(5). 379–382. 3 indexed citations

15.

Rius, Cristina, Patricia García de Olalla, Josep Álvarez, et al.. (2011). Pandemic A/H1N1 influenza: Transmission of the first cases in Spain. Enfermedades Infecciosas y Microbiología Clínica. 30(2). 60–63. 8 indexed citations

16.

Santín, Sheila, Bárbara Tazón‐Vega, Irene Silva, et al.. (2010). Clinical Value of NPHS2 Analysis in Early- and Adult-Onset Steroid-Resistant Nephrotic Syndrome. Clinical Journal of the American Society of Nephrology. 6(2). 344–354. 51 indexed citations

17.

Torrá, Roser, et al.. (2008). Preservation of renal function in a patient with Fabry nephropathy on enzyme replacement therapy. Clinical Nephrology. 69(6). 445–449. 9 indexed citations

18.

Consugar, Mark, Sarah Anderson, Sandro Rossetti, et al.. (2005). Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease. American Journal of Kidney Diseases. 45(1). 77–87. 24 indexed citations

19.

Torrá, Roser, et al.. (1999). Autosomal recessive Alport syndrome: linkage analysis and clinical features in two families. Nephrology Dialysis Transplantation. 14(3). 627–630. 12 indexed citations

20.

Hateboer, Nick, Marjan A. van Dijk, Nadja Bogdanova, et al.. (1999). Comparison of phenotypes of polycystic kidney disease types 1 and 2. The Lancet. 353(9147). 103–107. 433 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact